EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
CIBC Asset Management Inc Has $59.11 Million Stock Holdings in AbbVie Inc. $ABBV - Markets Daily
The Manufacturers Life Insurance Company Grows Stock Position in AbbVie Inc. $ABBV - Stock Observer
HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265
AbbVie (NYSE:ABBV) Raised to "Strong-Buy" at Hsbc Global Res - Daily Political
This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence
HSBC highlights one pharma stock to buy and one to sell for 2026
AbbVie Inc. $ABBV Shares Sold by Integrated Investment Consultants LLC
Gamco Investors INC. ET AL Grows Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
NewEdge Advisors LLC Has $103.13 Million Stake in AbbVie Inc. $ABBV - Daily Political
Botox brand struggles amid natural aging movement
Medincell Publishes its Consolidated Half-Year Financial Results
AbbVie Inc. $ABBV Shares Bought by State Street Corp
Daiwa Securities Group Inc. Buys 38,862 Shares of AbbVie Inc. $ABBV
Medical Aesthetic Devices Market Projected to Reach $37.9 Billion by 2029
Tripletail Wealth Management LLC Acquires New Holdings in AbbVie Inc. $ABBV - Daily Political
Certuity LLC Sells 2,442 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Shares Down 1.4% - Here's Why
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT) | Taiwan News | Dec. 9, 2025 05:30
SVB Wealth LLC Sells 113,330 Shares of AbbVie Inc. $ABBV
Ossiam Has $51.75 Million Holdings in AbbVie Inc. $ABBV
Gabelli Funds LLC Cuts Stock Holdings in AbbVie Inc. $ABBV
AbbVie Inc. (NYSE:ABBV) Receives $241.85 Consensus Price Target from Analysts - Markets Daily
Jump Financial LLC Buys New Shares in AbbVie Inc. $ABBV - Stock Observer
OSE Immunotherapeutics Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 Development | Taiwan News | Dec. 8, 2025 14:30
Ossiam Acquires 230,317 Shares of AbbVie Inc. $ABBV - Daily Political
ABBV: Future Performance Will Depend On Extended Exclusivity And Pipeline Execution
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma
Federated Hermes Inc. Acquires 134,942 Shares of AbbVie Inc. $ABBV
Cerity Partners LLC Has $210.15 Million Holdings in AbbVie Inc. $ABBV
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) | Taiwan News | Dec. 6, 2025 22:30
SageView Advisory Group LLC Increases Stock Position in AbbVie Inc. $ABBV - Markets Daily
SageView Advisory Group LLC Acquires 4,020 Shares of AbbVie Inc. $ABBV - Stock Observer
Is AbbVie's Expanding Migraine And Oncology Pipeline Reshaping The Investment Case For AbbVie (ABBV)?
StoneX Group Inc. Has $8.75 Million Stake in AbbVie Inc. $ABBV - Daily Political
Brokerages Set AbbVie Inc. (NYSE:ABBV) Target Price at $241.85 - Stock Observer
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) | Valuespectrum.com
AbbVie (NYSE:ABBV) Shares Down 1.1% - What's Next?
Marshall Wace LLP Grows Stake in AbbVie Inc. $ABBV
M Holdings Securities Inc. Increases Holdings in AbbVie Inc. $ABBV
Quantbot Technologies LP Takes Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Position Lifted by Epoch Investment Partners Inc.
AbbVie Inc. $ABBV Shares Purchased by Cresset Asset Management LLC - Daily Political
Kennedy Capital Management LLC Reduces Holdings in AbbVie Inc. $ABBV
First Trust Advisors LP Trims Stake in AbbVie Inc. $ABBV
Groupe la Francaise Purchases 6,466 Shares of AbbVie Inc. $ABBV
Baird Financial Group Inc. Sells 36,202 Shares of AbbVie Inc. $ABBV
Kennedy Capital Management LLC Lowers Stake in AbbVie Inc. $ABBV - Stock Observer
Best Pharmaceutical Stocks To Keep An Eye On - December 1st - Stock Observer
Assessing AbbVie's (ABBV) Valuation After New Cancer Data, EPKINLY Approval, and Dividend Hike
AbbVie (NYSE:ABBV) Shares Up 2.6% - What's Next?
AbbVie (NYSE:ABBV) Trading 2.6% Higher - Time to Buy? - Daily Political
Invesco Ltd. Lowers Stock Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Bought by CW Advisors LLC
AbbVie Inc. (NYSE:ABBV) Receives Average Rating of "Moderate Buy" from Analysts
Is It Too Late to Consider AbbVie After Its Strong Multi Year Share Price Rally?
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
Is AbbVie Stock Set for More Gains After 25% Rally and Product Launches?
AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.73
Portfolio Design Labs LLC Sells 4,734 Shares of AbbVie Inc. $ABBV - Markets Daily
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
Portfolio Design Labs LLC Has $571,000 Stake in AbbVie Inc. $ABBV
Loomis Sayles & Co. L P Purchases 18,866 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Fisher Asset Management LLC
FDA Approves Amneal Pharma's Generic Equivalent Of RESTASIS For Dry Eye Disease
Pharma company of the year award for AbbVie
Correction: Machine learning reveals limited predictive value of clinical factors for asthma exacerbations
AbbVie (NYSE:ABBV) Stock Price Down 1.3% - Here's What Happened
Sepio Capital LP Has $38.93 Million Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV is Distillate Capital Partners LLC's 4th Largest Position
AbbVie Inc. $ABBV Shares Purchased by Everstar Asset Management LLC
Smith Moore & CO. Lowers Holdings in AbbVie Inc. $ABBV - Stock Observer
Claret Asset Management Corp Trims Stock Holdings in AbbVie Inc. $ABBV - Daily Political
AbbVie Inc. $ABBV Shares Bought by VestGen Advisors LLC
Railway Pension Investments Ltd Lowers Position in AbbVie Inc. $ABBV
Northwestern Mutual Wealth Management Co. Grows Position in AbbVie Inc. $ABBV - Markets Daily
Wall Street Zen Downgrades AbbVie (NYSE:ABBV) to Buy
3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years
Virtue Capital Management LLC Sells 1,371 Shares of AbbVie Inc. $ABBV
Independent Family Office LLC Invests $215,000 in AbbVie Inc. $ABBV
Mackenzie Financial Corp Sells 162,035 Shares of AbbVie Inc. $ABBV - Markets Daily
West Family Investments Inc. Increases Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
New York State Common Retirement Fund Has $406.32 Million Stake in AbbVie Inc. $ABBV - Stock Observer
Assessing AbbVie's (ABBV) Valuation: Is There More Upside After Recent Performance?
Canadian Approval of SKYRIZI in Ulcerative Colitis Might Change the Case for Investing in AbbVie (ABBV)
First National Advisers LLC Has $4.16 Million Position in AbbVie Inc. $ABBV - Daily Political
AbbVie (NYSE:ABBV) Shares Down 1.8% - Should You Sell?
AbbVie Inc. $ABBV Shares Sold by Skandinaviska Enskilda Banken AB publ
AbbVie Inc. $ABBV Holdings Decreased by Neuberger Berman Group LLC
F m Investments LLC Raises Position in AbbVie Inc. $ABBV
Scotia Capital Inc. Purchases 7,991 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Bought by Level Four Advisory Services LLC
GM Advisory Group LLC Buys 3,164 Shares of AbbVie Inc. $ABBV
AbbVie News
Top cryptos to watch 2026: Bitcoin (BTC/USD), Starknet, Pi Network (PI) coin
Bitcoin (BTC) Price Prediction: How much will $1 Bitcoin be worth in 2026?
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?
Gold price analysis: XAU/USD price today, how high will gold go in 2026?
Technology stock to watch in 2026: What is the new NVDA stock price target?
